Oxcarbazepine-induced Steven–Johnson syndrome
Carbamazepine has been well documented to be associated with Steven–Johnson Syndrome (SJS). The newer anti-epileptic oxcarbazepine has not been demonstrated to be associated with this rare side effect except in some case reports. We present a case of SJS caused due to use of oxcarbazepine in a patie...
Gespeichert in:
Veröffentlicht in: | Archives of Mental Health 2021-07, Vol.22 (2), p.171-173 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Carbamazepine has been well documented to be associated with Steven–Johnson Syndrome (SJS). The newer anti-epileptic oxcarbazepine has not been demonstrated to be associated with this rare side effect except in some case reports. We present a case of SJS caused due to use of oxcarbazepine in a patient of schizophrenia. |
---|---|
ISSN: | 2589-9171 2589-918X |
DOI: | 10.4103/AMH.AMH_55_20 |